GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » EV-to-FCF

Biovica International AB (OSTO:BIOVIC B) EV-to-FCF : -0.41 (As of May. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Biovica International AB's Enterprise Value is kr48.40 Mil. Biovica International AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 was kr-119.48 Mil. Therefore, Biovica International AB's EV-to-FCF for today is -0.41.

The historical rank and industry rank for Biovica International AB's EV-to-FCF or its related term are showing as below:

OSTO:BIOVIC B' s EV-to-FCF Range Over the Past 10 Years
Min: -47.78   Med: -11.4   Max: -0.03
Current: -0.31

During the past 9 years, the highest EV-to-FCF of Biovica International AB was -0.03. The lowest was -47.78. And the median was -11.40.

OSTO:BIOVIC B's EV-to-FCF is ranked worse than
100% of 370 companies
in the Biotechnology industry
Industry Median: 9.66 vs OSTO:BIOVIC B: -0.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Biovica International AB's stock price is kr1.73. Biovica International AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was kr-2.574. Therefore, Biovica International AB's PE Ratio for today is At Loss.


Biovica International AB EV-to-FCF Historical Data

The historical data trend for Biovica International AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB EV-to-FCF Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only -7.01 -10.31 -26.54 -14.94 -2.33

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.27 -2.33 -2.73 -0.63 -1.02

Competitive Comparison of Biovica International AB's EV-to-FCF

For the Biotechnology subindustry, Biovica International AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Biovica International AB's EV-to-FCF falls into.



Biovica International AB EV-to-FCF Calculation

Biovica International AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=48.396/-119.477
=-0.41

Biovica International AB's current Enterprise Value is kr48.40 Mil.
Biovica International AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-119.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biovica International AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.73/-2.574
=At Loss

Biovica International AB's share price for today is kr1.73.
Biovica International AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.574.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Biovica International AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Biovica International AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines